Acurx Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACXP and other ETFs, options, and stocks.About ACXP
Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme.
CEODavid P. Luci
CEODavid P. Luci
Employees4
Employees4
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2017
Founded2017
Employees4
Employees4
ACXP Key Statistics
Market cap9.01M
Market cap9.01M
Price-Earnings ratio-0.51
Price-Earnings ratio-0.51
Dividend yield—
Dividend yield—
Average volume59.81K
Average volume59.81K
High today$4.37
High today$4.37
Low today$3.90
Low today$3.90
Open price$3.94
Open price$3.94
Volume57.81K
Volume57.81K
52 Week high$28.60
52 Week high$28.60
52 Week low$3.80
52 Week low$3.80
Stock Snapshot
Acurx Pharmaceuticals(ACXP) stock is priced at $4.35, giving the company a market capitalization of 9.01M. It carries a P/E multiple of -0.51.
On 2025-11-23, Acurx Pharmaceuticals(ACXP) stock moved within a range of $3.90 to $4.37. With shares now at $4.35, the stock is trading +11.5% above its intraday low and -0.5% below the session's peak.
Trading activity shows a volume of 57.81K, compared to an average daily volume of 59.81K.
The stock's 52-week range extends from a low of $3.80 to a high of $28.60.
The stock's 52-week range extends from a low of $3.80 to a high of $28.60.
People also own
Based on the portfolios of people who own ACXP. This list is generated using Robinhood data, and it’s not a recommendation.